Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 1989Statistics in Medicine

Surrogate endpoints in clinical trials: Cardiovascular diseases

View Full Paper
Ask AI
Bookmark
Share

Authors

JWJanet WittesHeart Failure & TransplantELEdward LakatosCincinnati Children's Hospital Medical CenterJPJeffrey L. ProbstfieldPreventive Cardiology

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wittes et al. (1989) studied this question.

synapsesocial.com/papers/69d56df875589c71d767d24chttps://doi.org/10.1002/sim.4780080405
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials1985 · 570 citations
  2. 2Survivorship patterns in the posthospital phase of myocardial infarction.1979 · 180 citations
  3. 3In-hospital mortality rates from acute myocardial infarction by race in U.S. hospitals: findings from the National Hospital Discharge Survey.1987 · 96 citations
  4. 4Beneficial Effects of Combined Colestipol-Niacin Therapy on Coronary Atherosclerosis and Coronary Venous Bypass Grafts1987 · 1,625 citations